Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

PDN Committee Members

Anna Kolodziejczak

Anna Kolodziejczak

Speaker

Anna Kolodziejczak, born in Poland, started her academic education at Poznan University of Medical Sciences where she studied Biotechnology. Before getting her M.Sc. degree, Anna was awarded the Fulbright foundation scholarship and spent a year at the University of Virginia investigating the role of checkpoint kinases in prostate cancer. This experience sparked her interest in DNA damage repair mechanisms, which turned out to be her main focus during her PhD at DKFZ. After defending her dissertation she joined the ADDRess consortium as a postdoctoral researcher. Her current project is focused on model development for Disorders with Abnormal DNA Damage Response (DADDRs) and drug screening in in-vitro and in-vivo settings. Outside of the lab she practices capoeira (10 years) and enjoys making training for beginners and intermediates as a member of the Brasilianisch-Deutsches Zentrum Heidelberg association.

Fiona Brown-Burke

Fiona Brown-Burke

Speaker

Fiona Brown-Burke was born and studied in the USA before moving to Germany in 2023. She recieved her PhD in Biomedical Sciences from the Ohio State University in 2023 with a project focused on novel therapeutics and mouse models for Mantle Cell Lymphoma. Currently she works in the division of Cancer Epigenomics, exploring how epigenetic hetereogeneity influences Acute Myeloid Leukemia. While interested in all things hematology, Fiona plans be involved in scientific policy to advocate for funding and support for researchers. Outside of lab, Fiona loves complex board games, exploring new resturants, and learning about all things Germany. If you are interested in working in the US, please reach out and Fiona would love to share her network and expertise.

Stefania Del Prete

Stefania Del Prete

Stefania was born in Naples and grew up in the North of Italy. She graduated in Molecular Biology at the University of Padova and then moved to Paris after she was awarded a Lifelong Learning Programme scholarship. She obtained a joint doctorate degree from the University of Paris-Saclay and the University of Amsterdam. During her PhD, funded by a Marie Curie fellowship, she focused on understanding gene regulation at the transcriptional and chromatin level in Arabidopsis. She did a first short postdoc at the Wellcome Trust Centre in Edinburgh, unravelling how bivalent chromatin domains, orchestrate the timely activation of genes in mouse embryonic stem cells. Her scientific interests are in the regulation of gene expression by chromatin proteins, impacting different levels of chromatin organization. She is known to invent new words mixing up the different languages she pretends to speak. She is also a foodie and she loves to punch in the air.

Cinthia Amaya Ramirez

Cinthia Amaya Ramirez

Cinthia was born in Peru, but she grew up in Italy, where she obtained her master degree in Health Biology at the University of Bologna. Afterwards, she won a fellowship to perform an internship in Berlin, at the MDC, in the group of Marina Chekulaeva; where she understood that her next steps must have been in research. She obtained her doctorate degree at the University of Heidelberg, working in the group of Julien Bethune. During her PhD, she focused on finding novel translational regulators factors, using also novel techniques such as Split Bio-ID. Currently, she is in the group of Fabricio Loayza-Puch where she is studying metabolic limitations in breast cancer, mainly applying ribosome profile techniques. She loves to talk to herself, so don't be scared if you find her talking alone. Following her Latino soul, she loves dancing and hears music.

Borja Gomez Ramos

Borja Gomez Ramos

Borja Gomez Ramos is a scientist specializing in investigating how cells maintain their identity and how its loss can lead to diseases such as cancer and neurodegeneration, utilizing transcriptomic and epigenomic methods. He obtained his PhD from the University of Luxembourg and currently serves as a postdoctoral researcher at the DKFZ. In this capacity, he utilizes a range of sophisticated techniques including molecular biology, iPSC, in vivo models, NGS, and bioinformatics to advance his research. Outside of work, he enjoys traveling, sports, and seeking new adventures with friends.

Simon Linder

Simon Linder

Simon studied Biomolecular Engineering at the Technical University of Darmstadt and received his PhD in Biomedical Engineering from Eindhoven University of Technology in 2023. He conducted his PhD research at the Netherlands Cancer Institute in Amsterdam, where he focused on improving our current understanding of hormonal signaling in prostate cancer to gain more insights into the cellular adaptation mechanisms that lead to acquired hormone therapy resistance by using integrative multi-omics approaches. In 2023, he was awarded a DKFZ postdoctoral fellowship and joined the division of Translational Medical Oncology. There, he uses integrative epigenomic profiling to unravel novel targetable vulnerabilities in rare cancers. In his spare time, Simon enjoys sports, traveling, spending time with friends and good coffee.

Contact

If you want to contact our PDN commitee, please send your message to the following e-mail address: 

pdn-committee(at)dkfz-heidelberg.de

to top
powered by webEdition CMS